Table 5.
Linking mechanisms to outcomes
| Mechanisms | Outcomes | |||
| All (n=24) | Successful deprescribing (n=15) | Attempted but failed deprescribing (n=4) | No attempt to deprescribe (n=5) | |
| Mean (SD) or % | Mean (SD) or % | Mean (SD) or % | Mean (SD) or % | |
| Increased motivation | ||||
| Change in knowledge (True or false/4) | ||||
| Baseline knowledge score | 1.4 (0.9) | 1.6 (0.9) | 1 (1.0) | 1.4 (0.5) |
| One-month knowledge score | 3.4 (0.9) | 3.8 (0.4) | 3.8 (0.4) | 2 (1.3) |
| Participants with an increase in knowledge score postintervention (%) | 92 | 100 | 100 | 60 |
| Change in beliefs (BMQS/25) | ||||
| Baseline beliefs about necessity score | 14.4 (5.9) | 13.3 (6.5) | 17.5 (4.3) | 15.2 (3.3) |
| One-month beliefs about necessity score | 11.3 (6.1) | 6.9 (3.5) | 16.5 (1.7) | 20 (0.9) |
| Participants with a decrease in necessity score postintervention (%) | 62.5 | 86.6 | 50 | 0 |
| Baseline concern score | 13.8 (6.5) | 13.9 (7.2) | 14.5 (5.6) | 11.2 (4.1) |
| One-month concern score | 17.7 (5.8) | 20.2 (5.1) | 18.5 (2.9) | 11 (3.5) |
| Participants with an increased concern score postintervention (%) | 79.1 | 93.3 | 75 | 40 |
| Building capacity | ||||
| Self-efficacy for deprescribing (SES/100) | ||||
| Baseline self-efficacy score | 48.5 (25.4) | 61.1 (20.1) | 38.8 (11.9) | 18.4 (15.3) |
| One-month self-efficacy score | 67.5 (34.1) | 81.7 (26.0) | 67.1 (28.8) | 25.4 (22.4) |
| Participants with an increased self-efficacy score postintervention (%) | 75.0 | 86.6 | 25.0 | 40.0 |
| Creating opportunity | ||||
| Outreach to a healthcare professional | ||||
| Participants that discussed/intended to discuss paracetamol use for low back pain with a health professional 1 week postintervention (%) | 50.0 | 33.3 | 50.0 | 40.0 |
| Participants that discussed/intend to discuss paracetamol use for low back pain with a health professional 1 month postintervention, (%) | 83.3 | 93.3 | 100.0 | 40.0 |
BMQS, Beliefs about Medications Specific Questionnaire; SES, Self Efficacy Scale.